Tech Company Financing Transactions
Respirics Funding Round
Respirics closed a $2.5 million Series A funding round on 6/20/2007. Investors included Hatteras Venture Partners and Research Triangle Ventures.
Transaction Overview
Company Name
Announced On
6/20/2007
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Series A
Proceeds Purpose
The financing will be used to accelerate a number of internal drug development programs involving the company's Acu-Breathe dry powder inhaler platform.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
2419 Willing Avenue
Fort Worth, TX 76110
USA
Fort Worth, TX 76110
USA
Phone
Website
Email Address
Overview
Respirics combines proprietary inhalation technology with powder drug formulation expertise to develop unique drug delivery solutions. The company is committed to bringing effective, easy-to-use and affordable inhalation drug products to the patients who need them.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Celeste
Chief Technical Officer
Robert Casper
VP - Administration
Terry Whitfield
Browse more venture capital transactions:
Prev: 6/20/2007: Arteris venture capital transaction
Next: 6/21/2007: Danal venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on tech company VC transactions. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs